Insider trades

Thomas K. Equels, CEO of AIM ImmunoTech AIM, has filed 21 purchases and 0 sales on the open market. The latest trade was on 03/12.

Thomas K. Equels

CEO & President
First filing
23/01/04
Trades
28 trades
Buys / sales
21 / 0
12-month net buying
No record
Last trade
03/12

Trading activity

Transactions

Trade type
Open-market buy25/06/1325/06/16107 sh$7.70$823.9+0.3%
Open-market buy25/06/1225/06/13103 sh$8.70$896.1+0.3%
Open-market buy25/04/1125/04/231,968,504 sh$0.03$59,055.12+103.7%
Open-market buy25/04/0425/04/0741,000 sh$0.06$2,460+2.2%
Open-market buy25/03/0525/03/0650,000 sh$0.13$6,500+2.8%
Open-market buy25/03/0425/03/0544,000 sh$0.12$5,280+2.5%
Open-market buy25/03/0425/03/0483,334 sh$0.12$10,000.08+5.0%
Open-market buy24/11/2125/01/2120,000 sh$0.21$4,200+1.2%
Open-market buy24/12/1824/12/1922,727 sh$0.21$4,772.67+1.4%
Open-market buy24/11/2024/11/2185,000 sh$0.20$17,000+5.5%
Open-market buy24/11/2024/11/2060,110 sh$0.18$10,819.8+4.0%
Open-market buy24/09/1624/09/175,000 sh$0.30$1,500+0.3%
Open-market buy24/09/1324/09/1620,000 sh$0.31$6,200+1.4%
Open-market buy24/05/0624/05/0761,729 sh$0.41$25,308.89+8.6%
Open-market buy24/03/1524/03/1875,758 sh$0.33$25,000.14+11.8%
Open-market buy23/11/2723/11/2733,861 sh$0.44$14,898.84+5.6%
Open-market buy23/09/2923/09/2922,676 sh$0.44$9,977.44+3.9%
Open-market buy23/08/2523/08/258,222 sh$0.67$5,508.74+1.4%
Open-market buy23/08/2423/08/2414,993 sh$0.67$10,045.31+2.7%
Open-market buy23/07/1723/07/1716,950 sh$0.59$10,000.5+3.1%